CYTK CYTOKINETICS INC
Nasdaq · SEC CIK 1061983 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $52.26M 81 sales by 10 insiders
- Filings on record
- 559 since 2021-07-02, latest 2026-09-22 18:14
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Blum Robert I | Pres, CEO, Dir | — | $17.08M |
| Callos Andrew | EVP, Chief Commercial Off | — | $16.02M |
| Lee Sung | EVP, CFO | — | $5.70M |
| Malik Fady Ibraham | EVP Research, Development | — | $4.65M |
| Kaye Edward M. MD | Dir | — | $3.21M |
| HENDERSON JOHN T | Dir | — | $2.08M |
| WIERENGA WENDELL | Dir | — | $1.88M |
| PARSHALL B LYNNE | Dir | — | $1.36M |
| Landry Robert E | Dir | — | $146.8K |
| Harrington Robert Arthur | Dir | — | $143.6K |
Transactions 784
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-09 | 2022-02-07 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $33.86 | -10.0K | 360.6K | -3% | -$338.6K |
| A | 2022-02-08 | 2021-04-01 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $24.44 | +409 | 7,819 | +6% | +$9,996 |
| 2022-01-04 | 2022-01-03 | CYTK | Bhanji Muna | Dir | A - Grant | $46.00 | +244 | 5,244 | +5% | +$11.2K | |
| 2022-01-04 | 2022-01-03 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $46.00 | +244 | 13.5K | +2% | +$11.2K | |
| 2022-01-04 | 2022-01-03 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $46.00 | +244 | 7,009 | +4% | +$11.2K | |
| 2022-01-04 | 2022-01-03 | CYTK | WIERENGA WENDALL | Dir | A - Grant | $46.00 | +122 | 6,887 | +2% | +$5,612 | |
| 2022-01-04 | 2022-01-03 | CYTK | Califf Robert | Dir | A - Grant | $46.00 | +122 | 6,003 | +2% | +$5,612 | |
| 2022-01-04 | 2022-01-03 | CYTK | Wysenski Nancy | Dir | A - Grant | $46.00 | +122 | 6,003 | +2% | +$5,612 | |
| 2022-01-04 | 2022-01-03 | CYTK | SMITH SANDFORD D | Dir | A - Grant | $46.00 | +122 | 6,887 | +2% | +$5,612 | |
| D | 2021-12-28 | 2021-12-27 | CYTK | WIERENGA WENDALL | Dir | M - OptEx | $5.46 | +4,166 | 10.9K | +62% | +$22.7K |
| D | 2021-12-28 | 2021-12-27 | CYTK | WIERENGA WENDALL | Dir | S - Sale+OE | $44.37 | -4,166 | 6,765 | -38% | -$184.8K |
| DM | 2021-12-28 | 2021-12-27 | CYTK | SMITH SANDFORD D | Dir | M - OptEx | $21.11 | +28.3K | 10.9K | New | +$597.2K |
| DM | 2021-12-28 | 2021-12-27 | CYTK | SMITH SANDFORD D | Dir | S - Sale+OE | $45.79 | -28.3K | 6,765 | -81% | -$1.30M |
| D | 2021-12-23 | 2021-12-23 | CYTK | Kaye Edward M. MD | Dir | M - OptEx | $7.61 | +15.0K | 21.8K | +222% | +$114.2K |
| D | 2021-12-23 | 2021-12-23 | CYTK | Kaye Edward M. MD | Dir | S - Sale+OE | $45.00 | -15.0K | 6,765 | -69% | -$675.0K |
| DM | 2021-12-09 | 2021-12-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $6.30 | +29.2K | 172.1K | +20% | +$183.7K |
| DM | 2021-12-09 | 2021-12-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $36.49 | -29.2K | 149.3K | -16% | -$1.06M |
| DM | 2021-11-19 | 2021-11-19 | CYTK | SMITH SANDFORD D | Dir | S - Sale+OE | $41.21 | -29.0K | 6,765 | -81% | -$1.20M |
| DM | 2021-11-19 | 2021-11-19 | CYTK | SMITH SANDFORD D | Dir | M - OptEx | $13.17 | +29.0K | 26.8K | New | +$382.2K |
| D | 2021-11-12 | 2021-11-12 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $39.63 | -4,143 | 360.1K | -1% | -$164.2K |
| D | 2021-11-12 | 2021-11-12 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.00 | +4,143 | 364.2K | +1% | +$24.9K |
| 2021-11-12 | 2021-11-11 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $39.56 | -2,000 | 148.9K | -1% | -$79.1K | |
| DM | 2021-11-09 | 2021-11-09 | CYTK | Cragg David | Chief HR, Admin Off | S - Sale+OE | $41.76 | -45.0K | 138.7K | -24% | -$1.88M |
| DM | 2021-11-09 | 2021-11-09 | CYTK | Cragg David | Chief HR, Admin Off | M - OptEx | $9.65 | +45.0K | 163.2K | +38% | +$434.2K |
| DM | 2021-11-08 | 2021-11-08 | CYTK | GAGE L PATRICK | Dir | M - OptEx | $4.25 | +26.5K | 51.2K | +107% | +$112.4K |
| DM | 2021-11-08 | 2021-11-08 | CYTK | GAGE L PATRICK | Dir | S - Sale+OE | $41.33 | -26.5K | 28.9K | -48% | -$1.09M |
| DM | 2021-11-05 | 2021-11-05 | CYTK | PARSHALL B LYNNE | Dir | S - Sale+OE | $40.00 | -31.0K | 5,000 | -86% | -$1.24M |
| DM | 2021-11-05 | 2021-11-05 | CYTK | PARSHALL B LYNNE | Dir | M - OptEx | $12.34 | +31.0K | 7,798 | New | +$382.4K |
| D | 2021-11-05 | 2021-11-05 | CYTK | HENDERSON JOHN T | Dir | M - OptEx | $5.88 | +8,503 | 21.8K | +64% | +$50.0K |
| D | 2021-11-05 | 2021-11-05 | CYTK | HENDERSON JOHN T | Dir | S - Sale+OE | $40.00 | -8,503 | 13.3K | -39% | -$340.1K |
| D | 2021-11-02 | 2021-10-29 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.00 | +5,000 | 365.1K | +1% | +$30.0K |
| D | 2021-11-02 | 2021-10-29 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $35.80 | -5,000 | 360.1K | -1% | -$179.0K |
| DM | 2021-11-02 | 2021-11-01 | CYTK | Cragg David | Chief HR, Admin Off | M - OptEx | $6.00 | +25.0K | 145.4K | +21% | +$150.0K |
| DM | 2021-11-02 | 2021-11-01 | CYTK | Cragg David | Chief HR, Admin Off | S - Sale+OE | $34.89 | -25.0K | 138.7K | -15% | -$872.2K |
| 2021-10-21 | 2021-10-19 | CYTK | Jaw Ching | CFO, SVP Fin | S - Sale | $35.73 | -35.7K | 53.1K | -40% | -$1.28M | |
| DM | 2021-10-20 | 2021-10-19 | CYTK | PARSHALL B LYNNE | Dir | M - OptEx | $6.65 | +10.3K | 6,999 | New | +$68.7K |
| DM | 2021-10-20 | 2021-10-19 | CYTK | PARSHALL B LYNNE | Dir | S - Sale+OE | $35.73 | -10.3K | 5,000 | -67% | -$369.2K |
| D | 2021-10-20 | 2021-10-19 | CYTK | SCHLOSSBERG MARK A | GC, SVP - Legal | M - OptEx | $7.03 | +20.0K | 70.8K | +39% | +$140.5K |
| D | 2021-10-20 | 2021-10-19 | CYTK | SCHLOSSBERG MARK A | GC, SVP - Legal | S - Sale+OE | $35.74 | -20.0K | 50.9K | -28% | -$714.0K |
| D | 2021-10-15 | 2021-10-14 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $37.74 | -5,000 | 357.6K | -1% | -$188.7K |
| D | 2021-10-15 | 2021-10-14 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.00 | +5,000 | 362.6K | +1% | +$30.0K |
| 2021-10-14 | 2021-10-14 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $37.73 | -2,000 | 150.9K | -1% | -$75.5K | |
| 2021-10-04 | 2021-10-01 | CYTK | Wysenski Nancy | Dir | A - Grant | $36.74 | +153 | 5,881 | +3% | +$5,621 | |
| 2021-10-04 | 2021-10-01 | CYTK | Califf Robert | Dir | A - Grant | $36.74 | +153 | 5,881 | +3% | +$5,621 | |
| 2021-10-04 | 2021-10-01 | CYTK | GAGE L PATRICK | Dir | A - Grant | $36.74 | +510 | 28.9K | +2% | +$18.7K | |
| 2021-10-04 | 2021-10-01 | CYTK | SMITH SANDFORD D | Dir | A - Grant | $36.74 | +306 | 6,765 | +5% | +$11.2K | |
| 2021-10-04 | 2021-10-01 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $36.74 | +306 | 13.3K | +2% | +$11.2K | |
| 2021-10-04 | 2021-10-01 | CYTK | WIERENGA WENDALL | Dir | A - Grant | $36.74 | +306 | 6,765 | +5% | +$11.2K | |
| 2021-10-04 | 2021-10-01 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $36.74 | +306 | 6,765 | +5% | +$11.2K | |
| D | 2021-10-01 | 2021-09-30 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $34.01 | -5,000 | 357.6K | -1% | -$170.1K |
| D | 2021-10-01 | 2021-09-30 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.00 | +5,000 | 362.6K | +1% | +$30.0K |
| 2021-10-01 | 2021-10-01 | CYTK | Cragg David | Chief HR, Admin Off | S - Sale | $35.14 | -7,569 | 137.1K | -5% | -$266.0K | |
| DM | 2021-09-17 | 2021-09-15 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $32.66 | -5,000 | 357.6K | -1% | -$163.3K |
| DM | 2021-09-17 | 2021-09-15 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.24 | +5,000 | 358.5K | +1% | +$31.2K |
| 2021-09-09 | 2021-09-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $31.43 | -2,000 | 152.9K | -1% | -$62.9K | |
| D | 2021-09-03 | 2021-09-02 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.30 | +5,000 | 362.6K | +1% | +$31.5K |
| D | 2021-09-03 | 2021-09-02 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $33.12 | -5,000 | 357.6K | -1% | -$165.6K |
| 2021-09-02 | 2021-09-01 | CYTK | Cragg David | Chief HR, Admin Off | S - Sale | $32.78 | -7,850 | 144.7K | -5% | -$257.3K | |
| D | 2021-08-20 | 2021-08-18 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.30 | +5,000 | 362.6K | +1% | +$31.5K |
| D | 2021-08-20 | 2021-08-18 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $31.14 | -5,000 | 357.6K | -1% | -$155.7K |
| 2021-08-13 | 2021-08-12 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $32.60 | -2,000 | 154.9K | -1% | -$65.2K | |
| D | 2021-08-06 | 2021-08-05 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.30 | +5,000 | 362.6K | +1% | +$31.5K |
| D | 2021-08-06 | 2021-08-05 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $29.12 | -5,000 | 357.6K | -1% | -$145.6K |
| 2021-08-02 | 2021-08-02 | CYTK | Cragg David | Chief HR, Admin Off | S - Sale | $29.67 | -2,616 | 152.5K | -2% | -$77.6K | |
| D | 2021-07-23 | 2021-07-22 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.30 | +5,000 | 362.6K | +1% | +$31.5K |
| D | 2021-07-23 | 2021-07-22 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $29.82 | -5,000 | 357.6K | -1% | -$149.1K |
| DM | 2021-07-21 | 2021-07-19 | CYTK | SMITH SANDFORD D | Dir | S - Sale+OE | $28.87 | -12.0K | 6,459 | -65% | -$345.5K |
| DM | 2021-07-21 | 2021-07-19 | CYTK | SMITH SANDFORD D | Dir | M - OptEx | $10.68 | +12.0K | 8,424 | New | +$127.8K |
| 2021-07-08 | 2021-07-07 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $19.77 | +63 | 6,459 | +1.0% | +$1,246 | |
| 2021-07-08 | 2021-07-07 | CYTK | SMITH SANDFORD D | Dir | A - Grant | $19.77 | +63 | 6,459 | +1.0% | +$1,246 | |
| 2021-07-08 | 2021-07-07 | CYTK | Wysenski Nancy | Dir | A - Grant | $19.77 | +31 | 5,728 | +0.5% | +$612.87 | |
| 2021-07-08 | 2021-07-08 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $19.48 | -2,000 | 156.9K | -1% | -$39.0K | |
| 2021-07-08 | 2021-07-07 | CYTK | WIERENGA WENDALL | Dir | A - Grant | $19.77 | +63 | 6,459 | +1.0% | +$1,246 | |
| M | 2021-07-08 | 2021-07-01+ | CYTK | HENDERSON JOHN T | Dir | A - Grant | $20.84 | +539 | 12.9K | +4% | +$11.2K |
| 2021-07-08 | 2021-07-07 | CYTK | Califf Robert | Dir | A - Grant | $19.77 | +31 | 5,728 | +0.5% | +$612.87 | |
| D | 2021-07-06 | 2021-07-06 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.30 | +5,000 | 362.6K | +1% | +$31.5K |
| D | 2021-07-06 | 2021-07-06 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $20.13 | -5,000 | 357.6K | -1% | -$100.7K |
| 2021-07-02 | 2021-07-01 | CYTK | Cragg David | Chief HR, Admin Off | S - Sale | $19.87 | -6,013 | 155.2K | -4% | -$119.5K | |
| 2021-07-02 | 2021-07-01 | CYTK | Wysenski Nancy | Dir | A - Grant | $20.98 | +238 | 5,697 | +4% | +$4,993 | |
| 2021-07-02 | 2021-07-01 | CYTK | SMITH SANDFORD D | Dir | A - Grant | $20.98 | +476 | 6,396 | +8% | +$9,986 | |
| 2021-07-02 | 2021-07-01 | CYTK | WIERENGA WENDALL | Dir | A - Grant | $20.98 | +476 | 6,396 | +8% | +$9,986 | |
| 2021-07-02 | 2021-07-01 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $20.98 | +476 | 6,396 | +8% | +$9,986 | |
| 2021-07-02 | 2021-07-01 | CYTK | GAGE L PATRICK | Dir | A - Grant | $20.98 | +893 | 28.4K | +3% | +$18.7K | |
| 2021-07-02 | 2021-07-01 | CYTK | Califf Robert | Dir | A - Grant | $20.98 | +238 | 5,697 | +4% | +$4,993 |
Purchase Sale Sale after option exercise All abbreviations